Hans Orlent, Hans

dr. Hans Orlent

Maag-, Darm- en Leverziekten

Radioactieve sferen voor de behandeling van leverkanker

Radioactieve sferen voor de behandeling van leverkanker

In de interventionele oncologie verscheen de voorbije jaren een “new kid on the block”, namelijk transarteriële radio-embolisatie (TARE), ook selectieve interne radiotherapie (SIRT) genoemd. De TARE-behandeling bestaat uit een katheterisatie van de patiënt via de … Lees meer

Nieuw endoscopieplatform optimaliseert centrale desinfectie

Nieuw endoscopieplatform optimaliseert centrale desinfectie

Hygiëne is een absolute prioriteit in een ziekenhuisomgeving. Gezien desinfectie- en sterilisatieprocessen van overheidswege steeds strikter geregulariseerd worden, wil het AZ Sint-Jan Brugge-Oostende AV deze taken over de diensten heen samenbrengen in een centraal “high level” desinfectieplatform. Dr. Hans Orlent stuurt voor de dienst Maag-, Darm- en Leverziekten de plannen om een nieuwe endoscopieinfrastructuur op te zetten en ziet ook voordelen in een overkoepelend endoscopieplatform voor de verschillende diensten die van deze techniek gebruikmaken. In een interview licht hij de pluspunten toe.

Bijblijven in hepatologie.

VVGE lentevergadering 2016
01/01/2016

Impact of intensive enteral nutrition in association with corticosteroids in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial.

Hepatology, Suppl 2014, 60, S1: A141.
01/01/2014

Psoriasis: targeted screening for hepatitis.

Oost en West Vlaanderen 2014
01/01/2014

1000 Levertransplantaties : een Odyssee voor patiënt en zorgverstrekker.

Gent
01/09/2013

Hépatites virales B et C en Belgique : similitudes et différences épidémiologiques et de prise en charge initiale.

JFHOD 2013. P007259.
01/01/2013

Radiofrequency in the esophagus: Results of a prospective multicentre Belgian Registry.

Acta Gastroenterol Belg; 2013, D05.
01/01/2013

New treatment options for HCV and their influence on diagnostic methods.

4th Scientific meeting Molecular Diagnostics.
01/12/2012

Cirrose: oorzaken, complicaties en behandeling.

KHBO Postgraduaat verpleegkunde.
01/11/2012

BASL winter meeting 2012 : Moderator.

BASL winter meeting 2012
01/01/2012

ACTUALITES EN HEPATO-GASTRO-ENTEROLOGIE. Utilité des polymorphismes génétiques dans le traitement de l’hépatite C.

Societe Royale Belge de Gastroenterologie.
15/10/2011

» http://www.ncbi.nlm.nih.gov/pubmed/

Are newly diagnosed patients with HBV and HCV infection different? Comparison between 2 prospective registries of the Belgian Association for the Study of the Liver .

J Hepatol 2011, S: A54.
01/01/2011

Prospective multicenter registry of hepatitis C virus genotype 4 from Belgium.

A Hepatology 2010, S: A778.
01/01/2010

Hepatitis B virus (HBV) infection in Belgium: Results of the Belgian Association for the Study of the Liver (BASL) registry of 1421 HBsAg chronic carriers.

J Hepatology; 2010, S276.
01/01/2010

Liver and brain: is there a link?

BASL winter meeting 2010.
01/01/2010

Hepatitis B Virus infection in Belgium: preliminary results of the Belgian association for the study of the liver (BASL) registry of HBsAg chronic carriers.

Hepatology 2009, S: A493.
01/01/2009

Hepatitis B-Delta Virus Co-Infection in Belgium: Preliminary Data of the BASL HDV Registr.

Asian-Pacific Association for the Study of the Liver Meeting 2009, Hong Kong. Hepatology International, 3(1), 200-201, abstract PE470.
01/01/2009

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies non responders to peginterferon-ribavirin combination therapy after 4 weeks of treatment.

Hepatology, 2008, S: A1236.
01/01/2008

Hepatitis C.

Antwerpen
22/11/2007

Traitements émergents en hépatogastroentérologie : comment les rendre accessibles à la pratique en Belgique ?

Société Royale Belge de Gastro
13/10/2007

BASL interuniversity liver course 2007: Moderator.

BASL interuniversity
01/01/2007

Hepatitis C en extrahepatische manifestaties.

Hepatitis C wereld dag
01/10/2006

High prevalence of the metabolic syndrome and GGT as a non-invasive marker of advanced fibrosis in a Belgian prospective cohort of NAFLD patients. AASLD Monothematic Conference: Alcoholic and Non-alcoholic Steatohepatitis.

Atlanta, 07-09.09.2006. Poster. Abstract in abstract-book.
07/09/2006

Een kok met acute epigastralgie.

VVGE: Het speciale geval.
01/09/2006

Chairmen for the lecture on “Surgery in patients with cirrhosis” followed by interactive discussion.

BASL winter meeting 2006
01/01/2006

Local Organizer.

BASL winter meeting 2006.
01/01/2006

Subobstructie.

VVGE: Het speciale geval.
01/09/2005

A pilot observational survey of hepatitis C in Belgium.

Acta Gastroenterologica Belg Suppl2005: A33.
01/01/2005

The BASL registry of non alcoholic fatty liver diesase (NAFLD).

Acta Gastroenterologica Belg Suppl2005: A15.
01/01/2005

Peginterferon and dose-titrated ribavirin for hepatitis C associated nephrotic membranoproliferative glomerulonephritis.

BASL winter meeting 2004
01/01/2004

Chronische hepatitis C met normale transaminasen en milde fibrose.

Gent
01/01/2004

Glycyrrhizin given as Stronger Neo-Minophagen C (SNMC) for the treatment of chronic hepatitis C: biochemical and histological effects after 26 weeks of treatment.

Hepatology, 2003, 38, S: A340.
01/01/2003

Endoscopische ballondilataties.

AIEVEV symposium 2002
01/01/2002

Toon meer

Prevention of Progression in Chronic Liver Disease- An Update on SNMC (Stronger Neo-Minophagen C).

SNMC in interferon non-responders with chronic hepatitis C: European experience in controlled trials. P110-114.
» http://www.ncbi.nlm.nih.gov/pubmed/

Versant HCV Genotype 2.0 assay (LiPA) misclassifies the circulating HCV recombinant RF1_2k/1b in genotype 2 patients.

Hepatology, 2016; 64, S1: A821.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Versant hcv genotype 2.0 line probe assay (lipa) misclassifies the circulating hcv recombinant rf1_2k/1b in genotype 2 patients .

Acta Gastroenterol Belg 2016;79(1): A36.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in Belgium: comparison with monoinfected patients and impact of hepatitis C virus replication.

Acta Gastroenterol Belg 2016;79(1): A33.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: real-life experience from Belgium.

Acta Gastroenterol Belg 2016;79(1): A08.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Light-to-moderate alcohol intake increases the risk of hepatocellular carcinoma in patients with hcv-related compensated cirrhosis: a prospective study.

Acta Gastroenterol Belg 2016;79(1): A01.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.

Gastroenterology 2016;150:903-10 e8.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series.

JIMD reports 2016;25:77-81.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Eikenella corrodens perinephric abscess due to pancreatic fistula in chronic pancreatitis.

Case report and literature review. Acta Gastroenterol Belg 2016; accepted.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection.

01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.

International journal of molecular sciences 2016;17.
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

“Heads or tails: genotyping of Hepatitis C Virus concerning the 2k/1b circulating recombinant form”.

International Journal of Molecular Sciences (Int J Mol Sci) 2016, 17(9),1384; doi:10.3390/ijms17091384
01/01/2016

» http://www.ncbi.nlm.nih.gov/pubmed/

Sofosbuvir in combination with Simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: real-life experience from Belgium.

Hepatology 2015;62, 1 (Suppl): A1091
01/01/2015

» http://www.ncbi.nlm.nih.gov/pubmed/

Efficacy, safety and pharmacokinetics of 12 weeks of simeprevir in combination with tmc647055, ritonavir and jnj-56914845 in genotype 1 hepatitis c virus-infected patients.

APASL 2015.
01/01/2015

» http://www.ncbi.nlm.nih.gov/pubmed/

A high number of advanced adenomas are found in individuals referred from the Flemish colon cancer screening program : a prospective single center quality registry.

Acta Gastroenterologica Belg 2015;78(1): A 105.
01/01/2015

» http://www.ncbi.nlm.nih.gov/pubmed/

Impact of intensive enteral nutrition in association with corticosteroids in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial.

Acta Gastroenterologica Belg 2015; 78(1): A 29.
01/01/2015

» http://www.ncbi.nlm.nih.gov/pubmed/

High-dose (peg)interferon therapy in treatment-naive, interleukin-28B rs12979860 CT/TT genotype 1 chronic hepatitis C.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2015;47:87-8.
01/01/2015

» http://www.ncbi.nlm.nih.gov/pubmed/

Impact of intensive enteral nutrition in association with corticosteroids in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial.

Hepatology, Suppl 2014, 60, S1: A141.
01/01/2014

» http://www.ncbi.nlm.nih.gov/pubmed/

High-dose (peg)interferon therapy in treatmentnaïve, interleukin-28B rs12979860 CT/TT genotype 1 chronic hepatitis C.

Digestive and Liver Disease 2014.
01/01/2014

» http://www.ncbi.nlm.nih.gov/pubmed/

Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.

Eur J Gastroenterol Hepatol 2013;25:613-9.
01/01/2013

» http://www.ncbi.nlm.nih.gov/pubmed/

Treatment of Chronic Hepatitis C Genotype 1 with Protease inhibitors: implications for the laboratory of molecular biology.

Noso Info. 2013, XVII (1):13-18.
01/01/2013

» http://www.ncbi.nlm.nih.gov/pubmed/

Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: A case report.

Hepatology research : the official journal of the Japan Society of Hepatology 2013;43:991-8.
01/01/2013

» http://www.ncbi.nlm.nih.gov/pubmed/

Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.

Eur J Gastroenterol Hepatol 2013;25:613-9.
01/01/2013

» http://www.ncbi.nlm.nih.gov/pubmed/

IL28B polymorphism and hepatitis C: a genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?

J Hepatol 2012;56:741-742
01/01/2012

» http://www.ncbi.nlm.nih.gov/pubmed/

Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.

Acta Gastroenterol Belg 2012;75:245-259
01/01/2012

» http://www.ncbi.nlm.nih.gov/pubmed/

IL28B polymorphism and hepatitis C: a genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?

J Hepatol 2012;56:741-2; author reply 2-3.
01/01/2012

» http://www.ncbi.nlm.nih.gov/pubmed/

Belgian Association for the Study of the L. Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.

Acta Gastroenterol Belg 2012;75:245-59.
01/01//2012

» http://www.ncbi.nlm.nih.gov/pubmed/

Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.

Acta Gastroenterol Belg 75, 245-259
01.01.2012

» http://www.ncbi.nlm.nih.gov/sites/

Are newly diagnosed patients with HBV and HCV infection different? Comparison between 2 prospective registries of the Belgian Association for the Study of the Liver .

J Hepatol 2011, S: A54.
01/01/2011

» http://www.ncbi.nlm.nih.gov/pubmed/

Steering Committee of the Belgian Association for the Study of the L. High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT.

Results of the Belgian NAFLD registry. Acta Gastroenterol Belg 2011;74:9-16.
01/01/2011

» http://www.ncbi.nlm.nih.gov/pubmed/

Belgian Association for the Study of the L. IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use?

Acta Gastroenterol Belg 2011;74:317-22.
01/01/2011

» http://www.ncbi.nlm.nih.gov/pubmed/

Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature.

Transpl Int 2011;24:e30-4.
01/01/2011

» http://www.ncbi.nlm.nih.gov/pubmed/

High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry.

Acta Gastroenterol Belg 2011;74(1):9-16
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

Are newly diagnosed patients with HBV and HCV infection different? Comparison between 2 prospective registries of the Belgian Association for the Study of the Liver.

Acta Gastroenterol Belg 2011;74(1): A21
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

IL28B polymorphism and hepatitis C: a genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?

J. Hepatol accepted
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

Hepatitis B-delta virus co-infection in Belgium: a multicenter BASL study. Prospective epidemiology and comparison to HBV mono-infection.

Acta Gastroenterol Belg Volume: in press
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

Progressive multifocal leucoencephalopathy in liver transplant recipents: a case report and review of the literature.

Transplant International 2011;24e30-4.doi:10.1111/j.1432-2277.2010.01190x
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

Are newly diagnosed patients with HBV and HCV infection different? Comparison between 2 prospective registries of the Belgian Association for the Study of the Liver .

Acta Gastroenterol Belg 2011;74(1): A21
01.01.2011

» http://www.ncbi.nlm.nih.gov/sites/

Hepatitis B virus (HBV) infection in Belgium: Results of the Belgian Association for the Study of the Liver (BASL) registry of 1421 HBsAg chronic carriers.

J Hepatology; 2010, S276.
01/01/2010

» http://www.ncbi.nlm.nih.gov/pubmed/

Hepatitis B virus (HBV) infection in Belgium: Results of the Belgian Association for the Study of the Liver (BASL) registry of 1421 HBsAg chronic carriers.

Acta Gastroenterol Belg; 2010;73(1), A97.
01/01/2010

» http://www.ncbi.nlm.nih.gov/pubmed/

Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients.

Eur J Gastroenterol Hepatol 2010;22:1253-9.
01/01/2010

» http://www.ncbi.nlm.nih.gov/pubmed/

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment.

Eur J Gastroenterol Hepatol 2010;22:1443-8.
01/01/2010

» http://www.ncbi.nlm.nih.gov/pubmed/

Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B.

Eur J Gastroenterol Hepatol 2010;22:494-9.
01/01/2010

» http://www.ncbi.nlm.nih.gov/pubmed/

Falk workshop. Prevention of Progression in Chronic Liver Disease- An Update on SNMC (Stronger Neo-Minophagen C). SNMC in interferon non-responders with chronic hepatitis C

European experience in controlled trials. P110-114.
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B.

Eur J Gastroenterol Hepatol 2010;22(4):494-9
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies non responders to peginterferon-ribavirin combination therapy after 4 weeks of treatment.

Eur J Gastroenterol Hepatol 2010:in press.
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients.

Eur J Gastroenterol Hepatol 2010;22(10):1253-9.
01.01.2010

» http://www.ncbi.nlm.nih.gov/sites/

Asian-Pacific Association for the Study of the Liver Meeting 2009, Hong Kong. Hepatitis B-Delta Virus Co-Infection in Belgium: Preliminary Data of the BASL HDV Registr.

Hong Kong, China, Hepatology International, 3(1), 200-201, abstract PE470
01.01.2009

» http://www.ncbi.nlm.nih.gov/sites/

Hepatitis B virus (HBV) infection in Belgium: Results of the Belgian Association for the Study of the Liver (BASL) registry of 1421 HBsAg chronic carriers.

Hepatology Suppl 2009: A493
01.01.2009

» http://www.ncbi.nlm.nih.gov/sites/

Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI.

J Magn Reson Imaging 2008;27:117-24.
01/01/2008

» http://www.ncbi.nlm.nih.gov/pubmed/

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies non responders to peginterferon-ribavirin combination therapy after 4 weeks of treatment.

Hepatology, Suppl 2008: A1236
01.01.2008

» http://www.ncbi.nlm.nih.gov/sites/

Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI.

JMRI 2008;27:117-24
01.01.2008

» http://www.ncbi.nlm.nih.gov/sites/

Société Royale Belge de Gastro 13 October 2007: Traitements émergents en hépatogastroentérologie: comment les rendre accessibles à la pratique en Belgique?: Moderator.

Société Royale Belge de Gastro 13 October 2007
13.10.2007

» http://www.ncbi.nlm.nih.gov/sites/

Belgian Association for the Study of the L. Management and treatment of chronic hepatitis B virus

Belgian Association for the Study of the Liver (BASL) 2007 guidelines. Acta Gastroenterol Belg 2007;70:389-420.
01/01/2007

» http://www.ncbi.nlm.nih.gov/pubmed/

Clinical challenges and images in GI. Fasciola hepatica infection and Von Hippel-Lindau disease type 1 with pancreatic and renal involvement.

Gastroenterology 2007;132:15-6, 467-8.
01/01/2007

» http://www.ncbi.nlm.nih.gov/pubmed/

Clinical challenges and images in GI. Fasciola hepatica infection and Von Hippel-Lindau disease type 1 with pancreatic and renal involvement.

Gastroenterology. 2007;132:15-6, 467-8
01.01.2007

» http://www.ncbi.nlm.nih.gov/sites/

Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.

Acta Gastroenterol Belg 2007;70:389-420.
01.01.2007

» http://www.ncbi.nlm.nih.gov/sites/

High prevalence of the metabolic syndrome and GGT as a non-invasive marker of advanced fibrosis in a Belgian prospective cohort of NAFLD patients. AASLD Monothematic Conference: Alcoholic and Non-alcoholic Steatohepatitis. (Atlanta, USA 07-09.09.2006)

Atlanta, USA;Abstract in abstract-book
07.09.2006

» http://www.ncbi.nlm.nih.gov/sites/

Acute pancreatitis after double-balloon enteroscopy: an old pathogenetic theory revisited as a result of using a new endoscopic tool.

Endoscopy 2006;38:82-5.
01/01/2006

» http://www.ncbi.nlm.nih.gov/pubmed/

Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.

J Hepatol 2006;45:539-46.
01/01/2006

» http://www.ncbi.nlm.nih.gov/pubmed/

High prevalence of the metabolic syndrome and GGT as a non-invasive marker of advanced fibrosis in a Belgian prospective cohort of NAFLD patients.

AASLD Monothematic Conference: Alcoholic and Non-alcoholic Steatohepatitis. Atlanta, 07-09.09.2006. Poster. Abstract in abstract-book.
01.01.2006

» http://www.ncbi.nlm.nih.gov/sites/

Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.

J Hepatol 2006;45(4):539-46.
01.01.2006

» http://www.ncbi.nlm.nih.gov/sites/

Acute pancreatitis after double-balloon enteroscopy: an old pathogenetic theory revisited as a result of using a new endoscopic tool.

Endoscopy 2006;38(1):82-5
01.01.2006

» http://www.ncbi.nlm.nih.gov/sites/

Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1.

Dig Dis Sci 2005;50:1804-6.
01/01/2005

» http://www.ncbi.nlm.nih.gov/pubmed/

Isolated increase of the serum aspartate aminotransferase level in a young asymptomatic patient: macro-AST.

Ned Tijdschr Geneeskd 2005;149:2807-9.
01/01/2005

» http://www.ncbi.nlm.nih.gov/pubmed/

Steering Committee of the Belgian Association for the Study of the L. The management of patients with mild hepatitis C.

Acta Gastroenterol Belg 2005;68:314-8.
01/01/2005

» http://www.ncbi.nlm.nih.gov/pubmed/

Isolated increase of the serum aspartate aminotransferase level in a young asymptomatic patient: macro-AST

Ned Tijdschr Geneeskd 2005;149(50):2807-9
01.01.2005

» http://www.ncbi.nlm.nih.gov/sites/

Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1.

Dig Dis Sci 2005;50(10):1804-6
01.01.2005

» http://www.ncbi.nlm.nih.gov/sites/

BASL winter meeting 2004: Peginterferon and dose-titrated ribavirin for hepatitis C associated nephrotic membranoproliferative glomerulonephritis.

BASL
01.01.2004

» http://www.ncbi.nlm.nih.gov/sites/

Glycyrrhizin given as Stronger Neo-Minophagen C (SNMC) for the treatment of chronic hepatitis C: biochemical and histological effects after 26 weeks of treatment.

Hepatology, Suppl 2003(38): A340
01.01.2003

» http://www.ncbi.nlm.nih.gov/sites/

Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation. Bone Marrow Transplant.

Transplant 2003;32(1):115-7.
01.01.2003

» http://www.ncbi.nlm.nih.gov/sites/
Toon meer